2024-01-03 09:05:12
Sanofi is the leading European pharmaceutical group. The turnover by product family is distributed as follows: – pharmaceutical products (71.4%): prescription drugs in the fields of specialty medicine (54.7% of turnover; intended for the treatment of multiple sclerosis, neurological diseases, inflammatory diseases, autoimmune diseases, rare diseases, cancers and rare hematological diseases) and general medicine (45.3%; intended mainly for the treatment of diabetes and cardiovascular diseases); – human vaccines (16.8%): pediatric vaccines, vaccines once morest influenza, meningitis and poliomyelitis, booster vaccines and vaccines intended for travelers and endemic areas; – consumer health products (11.8%). At the end of 2022, the group has 59 production sites around the world. The geographical distribution of turnover is as follows: France (5.3%), Europe (18%), United States (42.5%), China (7.3%), Japan (3.8%), Brazil (2.1%), Russia (1.5%) and others (19.5%).
More information regarding the company
1704275022
#SANOFI #Morgan #confirms #neutral #recommendation #January #a.m
